| 1 |
Incorporating clinical research into recommendations for addressing global mental health needs: Updating the World Health Organizationęs Essential Medicines List |
|
| | Iona K. Machado,Csilla Lippert,Michael J. Ostacher | | | Comprehensive Psychiatry. 2021; : 152245 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder |
|
| | Mahmoud S. Abdallah,Ahmed N. Ramadan,Hend Omara-Reda,Noha O. Mansour,Mohamed A. Elsokary,Hozaifa K. Elsawah,Shimaa Abdelsattar Zaki,Hend E. Abo Mansour,Esraa M. Mosalam | | | CNS Neuroscience & Therapeutics. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Efficacy and safety of escitalopram in treatment of severe depression in Chinese population |
|
| | Tianmei Si,Gang Wang,Fude Yang,Yiru Fang,Maosheng Fang,Jijun Li,Jicheng Dong,Xinhua Shen,Jianmin Zhuo,Qing Rui,Jinan Wang,Hu Cuili | | | Metabolic Brain Disease. 2017; 32(3): 891 | | | [Pubmed] [Google Scholar] [DOI] | |
|
